BIOMEDITECH ApS: Financial statements 2020
CVR: 34707847
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
BIOMEDITECH ApS (CVR 34707847) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 27,491 and a net result of DKK 16,722 compared with DKK -13,184 the year before. The profit margin was 60.8%. Equity in the 2020 report amounted to DKK 50,887. The solvency ratio was 100%.
- Revenue
- DKK 27,491
- Gross Profit
- DKK 26,679
- Profit/Loss
- DKK 16,722
- Equity
- DKK 50,887
- Total Assets
- DKK 50,887
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 27K | 27K | 17K | 51K | - |
| 2019 | - | - | -13K | 34K | - |
| 2018 | - | - | -18K | 47K | - |
| 2017 | - | - | -28K | 65K | - |
| 2016 | - | - | -31K | 93K | - |
Official annual report
How creditworthy is BIOMEDITECH ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of August 13, 2020, Chalmer Holding ApS is registered as an owner of BIOMEDITECH ApS with an ownership share of 100%.
BIOMEDITECH ApS has published its annual report for 2019. The net result was DKK -13,184.
About BIOMEDITECH ApS
BIOMEDITECH ApS is a Danish company of the type Anpartsselskab based in Herlev, founded in 2012. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named DRUG TESTING EUROPE ApS. The management consists of Tobias Chalmer Stahl Rasmussen. The company is owned by Chalmer Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 106,895 and a net result of DKK -6,298 compared with DKK 290,046 the year before. Equity in the 2025 report amounted to DKK 877,884.